Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$43.4 - $62.52 $1.05 Million - $1.52 Million
-24,288 Reduced 32.37%
50,751 $2.25 Million
Q2 2023

Aug 11, 2023

SELL
$47.08 - $55.16 $2.35 Million - $2.76 Million
-50,004 Reduced 39.99%
75,039 $3.65 Million
Q1 2023

May 12, 2023

BUY
$36.57 - $58.29 $2.62 Million - $4.17 Million
71,551 Added 133.76%
125,043 $6.94 Million
Q4 2022

Feb 13, 2023

SELL
$34.17 - $47.91 $1.77 Million - $2.48 Million
-51,709 Reduced 49.15%
53,492 $2.15 Million
Q3 2022

Nov 14, 2022

BUY
$36.93 - $56.68 $1.15 Million - $1.77 Million
31,154 Added 42.07%
105,201 $4.61 Million
Q2 2022

Aug 12, 2022

SELL
$28.13 - $44.54 $1.57 Million - $2.49 Million
-55,897 Reduced 43.02%
74,047 $2.62 Million
Q1 2022

May 13, 2022

BUY
$30.32 - $91.33 $163,546 - $492,634
5,394 Added 4.33%
129,944 $5.29 Million
Q4 2021

Feb 11, 2022

BUY
$86.26 - $119.0 $2.98 Million - $4.11 Million
34,503 Added 38.32%
124,550 $11.6 Million
Q3 2021

Nov 12, 2021

SELL
$100.17 - $126.36 $3.06 Million - $3.85 Million
-30,500 Reduced 25.3%
90,047 $10 Million
Q2 2021

Aug 13, 2021

SELL
$86.05 - $119.72 $1.66 Million - $2.32 Million
-19,346 Reduced 13.83%
120,547 $13.7 Million
Q1 2021

May 14, 2021

BUY
$91.47 - $124.36 $1.74 Million - $2.37 Million
19,026 Added 15.74%
139,893 $14.2 Million
Q4 2020

Feb 12, 2021

SELL
$66.66 - $111.74 $3.62 Million - $6.07 Million
-54,294 Reduced 31.0%
120,867 $12 Million
Q3 2020

Nov 13, 2020

BUY
$45.89 - $72.67 $1.15 Million - $1.82 Million
25,028 Added 16.67%
175,161 $12.7 Million
Q2 2020

Aug 13, 2020

BUY
$26.36 - $49.86 $1.71 Million - $3.24 Million
65,000 Added 76.35%
150,133 $7.49 Million
Q1 2020

May 15, 2020

SELL
$17.27 - $40.17 $1.13 Million - $2.64 Million
-65,710 Reduced 43.56%
85,133 $2.54 Million
Q4 2019

Feb 13, 2020

BUY
$32.1 - $40.4 $4.84 Million - $6.09 Million
150,843 New
150,843 $5.08 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.